Prostate Cancer

The promotion of cell migration and anoikis resistance by Rad9 contributes to prostate tumor progression, "Beyond the Abstract," by Constantinos G. Broustas and Howard B. Lieberman

Published on Tuesday, 21 May 2013 10:24

BERKELEY, CA (UroToday.com) - Prostate cancer is the most prevalent non-cutaneous type of cancer in men.

Does robotic prostatectomy meet its promise in the management of prostate cancer? - Abstract

Published on Tuesday, 21 May 2013 07:18

Following Walsh's advances in pelvic anatomy and surgical technique to minimize intraoperative peri-prostatic trauma more than 30 years ago, open retropubic radical prostatectomy (RRP) evolved to become the gold standard treatment of localized prostate cancer, with excellent long-term survival outcomes [1•].

A reference set of health utilities for long-term survivors of prostate cancer: Population-based data from Ontario, Canada - Abstract

Published on Tuesday, 21 May 2013 07:14

PURPOSE: To measure quality of life (QOL) and utilities for prostate cancer (PC) patients and determine their predictors.

Comparison of biochemical recurrence free survival between periprostatic and pelvic lymph node metastases of prostate cancer - Abstract

Published on Tuesday, 21 May 2013 07:10

Objective: To assess the pathologic characteristics and prognostic significance of periprostatic lymph node (LN) metastasis of prostate cancer.

Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard - Abstract

Published on Tuesday, 21 May 2013 07:01

Purpose: To evaluate the diagnostic performance of multiparametric (MP) magnetic resonance (MR) imaging for prostate cancer detection by using transperineal template prostate mapping (TTPM) biopsies as the reference standard and to determine the potential ability of MP MR imaging to identify clinically significant prostate cancer.

Delayed radiotherapy for patients with localized prostate cancer: Validation by propensity score matching - Abstract

Published on Tuesday, 21 May 2013 06:54

AIM: To retrospectively investigate the biochemical outcome following delayed radiotherapy in patients with prostate cancer.

Improved therapeutic targeting of the androgen receptor: Rational drug design improves survival in castration-resistant prostate cancer - Abstract

Published on Tuesday, 21 May 2013 06:24

The growth and dependence of Prostate Cancer (PCa) on androgen stimulation led to the use of castration to reduce circulating levels of androgens and anti-androgens to directly target the androgen receptor (AR) ligand-binding domain (LBD).

Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma - Abstract

Published on Tuesday, 21 May 2013 06:19

OBJECTIVE: To evaluate the feasibility of the transperineal implementation of biocompatible balloon (Prospace) and the acute toxicity of high dose 3DCRT in patients with localized low risk prostate cancer.